Steady-state levels of reactive oxygen species (ROS) and oxidative damage to cellular macromolecules are increased in the rodent hippocampus during epileptogenesis. However, the role of reactive nitrogen species (RNS) in epileptogenesis remains to be explored. The goal of this study was to determine the spatial and temporal occurrence of RNS i.e. nitric oxide levels in a rat model of temporal lobe epilepsy (TLE). Rats were injected with a single high dose of kainate and monitored by video for behavioral seizures for 6 weeks to determine the onset and severity of chronic seizures. RNS and tissue/mitochondrial redox status (glutathione redox couple and coenzyme A:glutathione redox couple) were measured in the hippocampus at 8 h, 24 h, 48 h, 1 wk, 3 wk and 6 wk following kainate to assess the level of reactive species in subcellular compartments. We observed a biphasic increase in RNS levels with a return to control values at the 48 h time point. However, both tissue and mitochondrial redox status showed permanent and significant decreases during the entire time course of epilepsy development. 3 nitrotyrosine (3NT) protein adducts were found to gradually increase throughout epileptogenesis, conceivably as a result of the local environment under oxidative and nitrosative stress. Colocalization of 3NT immunostaining with neuron-or astrocyte-specific markers revealed neuron-specific localization of 3NT in hippocampal principal neurons. Persistent and concurrent glutathione oxidation and nitrosative stress occur during epileptogenesis suggesting a favorable environment for posttranslational modifications.
Introduction
Temporal lobe epilepsy (TLE), the most common form of acquired epilepsy, is initiated by an injury such as head trauma, hypoxia, complex febrile seizures or status epilepticus (SE) (Delgado-Escueta et al., 1999) . These precipitating injuries initiate molecular, biochemical, and structural alterations which result in the development of spontaneous recurrent seizures i.e. epilepsy. The process whereby injury culminates in network excitability or epileptogenesis is thought to involve several processes such as neuronal loss, gliosis, gene regulation, axonal sprouting, inflammation and neurogenesis. However, the role of reactive oxygen species (ROS) and reactive nitrogen species (RNS) in epileptogenesis is poorly understood (Waldbaum and Patel, 2010) .
Abundant and overlapping endogenous antioxidants exist to overcome normal cellular production of reactive species; yet excessive production of ROS and RNS can overwhelm antioxidant defenses, shift the redox state of the local cellular environment and cause oxidation of vulnerable cellular targets. Studies from our laboratory and others have shown that oxidative stress arising from mitochondria and the plasma membrane/extracellular space via Nox2 contributes to seizure associated neuronal damage (Liang et al., 2000; Patel et al., 2005) . Using surrogate markers of target oxidation in two separate TLE models (kainate and lithium-pilocarpine), we also showed that indices of ROS increase throughout epileptogenesis (Liang and Patel, 2006; Liang et al., 2000; Patel et al., 2008) .
Much less is known about the link between nitrosative stress, or increased RNS, and epileptogenesis. One reason for this is the difficulty associated with accurately measuring various RNS species in biological systems. Current techniques each have their own limitations and it is critical to understand the specificity, limit of detection, and range at which RNS can be measured before experimentation. However, studies have shown that SE can result in a rapid increase of brain nitric oxide (NO) (Alderton et al., 2001; Sharma et al., 2008) . The pathological effects of excess NO are proposed to be through the generation of the highly reactive nitrating species peroxynitrite (ONOO − ) in the presence of superoxide (O 2 • − ) (Szabo et al., 2007) . Adverse consequences of RNS include induction of apoptotic pathways, potentiation of excitotoxicity through inhibition of glutamate reuptake, modulation of phosphorylation pathways and aberrant posttranslational modifications (PTMs) (Aguiar et al., 2012 
